Missing/wrong data?
Log in to edit
Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in t
scientific article published on 30 December 2013
Author/s
author: Simona Soverini, Cristina Papayannidis, Mario Luppi, Gian Matteo Rigolin, Michele Cavo, Caterina De Benedittis
Work details
Publication date
December 30, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.